{"url":"https://lda.senate.gov/api/v1/filings/add337ba-e045-438e-956d-acdde1f8d6f9/","filing_uuid":"add337ba-e045-438e-956d-acdde1f8d6f9","filing_type":"RR","filing_type_display":"Registration","filing_year":2016,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/add337ba-e045-438e-956d-acdde1f8d6f9/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Timothy F. Powers","dt_posted":"2016-10-24T15:29:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"10 G Street, NE","registrant_address_2":"Suite 601","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":82990,"url":"https://lda.senate.gov/api/v1/registrants/82990/","house_registrant_id":36401,"name":"ARTEMIS STRATEGIES","description":"consultant","address_1":"P.O. Box 384","address_2":null,"address_3":null,"address_4":null,"city":"Waterford","state":"VA","state_display":"Virginia","zip":"20197","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TIM POWERS","contact_telephone":"+1 202-359-6871","dt_updated":"2022-04-06T16:06:43.011497-04:00"},"client":{"id":171877,"url":"https://lda.senate.gov/api/v1/clients/171877/","client_id":1507,"name":"ALKERMES PHARMACEUTICALS CORPORATION","general_description":"Pharmaceuticals development and manufacturing","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-05-05"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":16459,"prefix":"mr","prefix_display":"MR.","first_name":"TIMOTHY","nickname":null,"middle_name":"F","last_name":"POWERS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"ALKERMES PLC","contribution":"0.00","ownership_percentage":"100.00","address":"1 Burlington Road","city":"Dublin","state":null,"state_display":null,"country":"IE","country_display":"Ireland","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"IE","ppb_country_display":"Ireland"}],"affiliated_organizations":[]}